Yeoman C, Chia N, Yildirim S, Miller M, Kent A, Stumpf R
Entropy (Basel). 2025; 13(3):570-594.
PMID: 39963611
PMC: 11831856.
DOI: 10.3390/e13030570.
Li S, Armstrong A, Neff C, Shaffer M, Lozupone C, Palmer B
Clin Pharmacol Ther. 2016; 99(6):600-11.
PMID: 26940481
PMC: 4927263.
DOI: 10.1002/cpt.363.
Huang B, Fettweis J, Brooks J, Jefferson K, Buck G
Clin Lab Med. 2014; 34(4):747-61.
PMID: 25439274
PMC: 4254509.
DOI: 10.1016/j.cll.2014.08.006.
Doolittle J, Webster-Cyriaque J
mBio. 2014; 5(3):e01015-14.
PMID: 24781742
PMC: 4010825.
DOI: 10.1128/mBio.01015-14.
Kovachev S
Microb Ecol. 2014; 68(2):173-84.
PMID: 24711012
DOI: 10.1007/s00248-014-0414-5.
Polyethylene glycol-based hydrogels for controlled release of the antimicrobial subtilosin for prophylaxis of bacterial vaginosis.
Sundara Rajan S, Cavera V, Zhang X, Singh Y, Chikindas M, Sinko P
Antimicrob Agents Chemother. 2014; 58(5):2747-53.
PMID: 24566190
PMC: 3993243.
DOI: 10.1128/AAC.02446-14.
Susceptibility of Gardnerella vaginalis biofilms to natural antimicrobials subtilosin, ε-poly-L-lysine, and lauramide arginine ethyl ester.
Turovskiy Y, Cheryian T, Algburi A, Wirawan R, Takhistov P, Sinko P
Infect Dis Obstet Gynecol. 2012; 2012:284762.
PMID: 23024575
PMC: 3457663.
DOI: 10.1155/2012/284762.
Understanding vaginal microbiome complexity from an ecological perspective.
Hickey R, Zhou X, Pierson J, Ravel J, Forney L
Transl Res. 2012; 160(4):267-82.
PMID: 22683415
PMC: 3444549.
DOI: 10.1016/j.trsl.2012.02.008.
Generation of recombinant single-chain antibodies neutralizing the cytolytic activity of vaginolysin, the main virulence factor of Gardnerella vaginalis.
Pleckaityte M, Mistiniene E, Lasickiene R, Zvirblis G, Zvirbliene A
BMC Biotechnol. 2011; 11:100.
PMID: 22047084
PMC: 3226441.
DOI: 10.1186/1472-6750-11-100.
Incidence of herpes simplex virus type 2 in young reproductive age women in Mysore, India.
Madhivanan P, Chen Y, Krupp K, Arun A, Klausner J, Reingold A
Indian J Pathol Microbiol. 2011; 54(1):96-9.
PMID: 21393886
PMC: 3625929.
DOI: 10.4103/0377-4929.77336.
The aetiology of bacterial vaginosis.
Turovskiy Y, Sutyak Noll K, Chikindas M
J Appl Microbiol. 2011; 110(5):1105-28.
PMID: 21332897
PMC: 3072448.
DOI: 10.1111/j.1365-2672.2011.04977.x.
.
Chavez N, Molina H, Sanchez J, Gelaye B, Sanchez S
Rev Peru Med Exp Salud Publica. 2010; 26(3):299-306.
PMID: 21132048
PMC: 2995200.
Bacterial vaginosis: identifying research gaps proceedings of a workshop sponsored by DHHS/NIH/NIAID.
Marrazzo J, Martin D, Watts D, Schulte J, Sobel J, Hillier S
Sex Transm Dis. 2010; 37(12):732-44.
PMID: 21068695
PMC: 3137891.
DOI: 10.1097/OLQ.0b013e3181fbbc95.
Comparative genomics of Gardnerella vaginalis strains reveals substantial differences in metabolic and virulence potential.
Yeoman C, Yildirim S, Thomas S, Durkin A, Torralba M, Sutton G
PLoS One. 2010; 5(8):e12411.
PMID: 20865041
PMC: 2928729.
DOI: 10.1371/journal.pone.0012411.
Analysis of adherence, biofilm formation and cytotoxicity suggests a greater virulence potential of Gardnerella vaginalis relative to other bacterial-vaginosis-associated anaerobes.
Patterson J, Stull-Lane A, Girerd P, Jefferson K
Microbiology (Reading). 2009; 156(Pt 2):392-399.
PMID: 19910411
PMC: 2890091.
DOI: 10.1099/mic.0.034280-0.
Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies.
Atashili J, Poole C, Ndumbe P, Adimora A, Smith J
AIDS. 2008; 22(12):1493-501.
PMID: 18614873
PMC: 2788489.
DOI: 10.1097/QAD.0b013e3283021a37.
Diversity of human vaginal bacterial communities and associations with clinically defined bacterial vaginosis.
Oakley B, Fiedler T, Marrazzo J, Fredricks D
Appl Environ Microbiol. 2008; 74(15):4898-909.
PMID: 18487399
PMC: 2519371.
DOI: 10.1128/AEM.02884-07.
Prevalence of RTI/STI agents and HIV infection in symptomatic and asymptomatic women attending peripheral health set-ups in Delhi, India.
Ray K, Bala M, Bhattacharya M, Muralidhar S, Kumari M, Salhan S
Epidemiol Infect. 2007; 136(10):1432-40.
PMID: 18081951
PMC: 2870727.
DOI: 10.1017/S0950268807000088.
The role of a regular sex partner in sexually transmitted infections and reinfections: results from the study of female entertainment establishment workers in the Philippines.
Chiao C, Morisky D
Sex Transm Dis. 2007; 34(8):534-40.
PMID: 17710751
PMC: 3106109.
A pilot clinical trial comparing an acid-buffering formulation (ACIDFORM gel) with metronidazole gel for the treatment of symptomatic bacterial vaginosis.
Simoes J, Bahamondes L, Camargo R, Alves V, Zaneveld L, Waller D
Br J Clin Pharmacol. 2006; 61(2):211-7.
PMID: 16433875
PMC: 1884999.
DOI: 10.1111/j.1365-2125.2005.02550.x.
